全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1198408-35-3 | Tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate;4-(6-Amino-3-pyridyl)-1-Boc-piperidine | C15H23N3O2 |
| 1198408-39-7 | N-(2-Chlorophenyl)-6-(4-piperidinyl)-imidazo[1,2-a]pyridine-3-carboxamide | C19H19ClN4O |
| 1198408-78-4 | N-(2-Chlorophenyl)-6-(4-piperidinyl)tmidazo[1,2-a]pyridine-3-carboxamide ethanedioate (1:1) | C19H19ClN4O.C2H2O4 |
| 1198569-35-5 | 3-Bromopyrazolo[1,5-a]pyrimidin-5(4H)-one | C6H4BrN3O |
| 1198791-58-0 | (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentynoic acid | C21H19NO4 |
| 1198791-65-9 | (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentynoic acid | C21H19NO4 |
| 1198791-73-9 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-[(4-methoxyphenyl)diphenylmethyl]-D-cysteine | C38H33NO5S |
| 1199589-74-6 | Risperidone EP Impurity D;3-[2-[4-(5-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | C23H27FN4O2 |
| 1199616-66-4 | 5H-Benzofuro[3,2-c]carbazole | C18H11NO |
| 1199631-29-2 | (1S)-3,3'-Bis(4-methoxyphenyl)[1,1'-binaphthalene]-2,2'-diol | C34H26O4 |
| 1199773-09-5 | 4-(5-Bromo-3-chloro-2-pyridinyl)morpholine | C9H10BrClN2O |
| 1199773-45-9 | 3-Bromo-5-chloro-4-methyl-2(1H)-pyridinone | C6H5BrClNO |
| 1199773-80-2 | 2-Pyrrolidinecarbonitrile hydrochloride | C5H8N2.HCl |
| 1199796-29-6 | 6alpha-Ethyl-23(S)-methylcholic acid;INT 777; S-EMCA | C27H46O5 |
| 1199943-44-6 | (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | C21H29NO |
| 1200130-82-0 | 6-Bromo-4-iodonicotinic acid | C6H3BrINO2 |
| 1200131-07-2 | 4-Bromo-2,6-diethylbenzonitrile | C11H12BrN |
| 1200828-74-5 | Ethyl 2-bromo-2-cyclopropylacetate | C7H11BrO2 |
| 1201080-09-2 | N-(3-Cyano-7-ethoxy-1,4-dihydro-4-oxo-6-quinolinyl)acetamide | C14H13N3O3 |
| 1201186-54-0 | 2-Bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine;2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine; 2-Bromo-5-(4-methylphenylsulfonyl)-5H-pyrrolo[2,3-b]pyrazine | C13H10BrN3O2S |
| 1201187-44-1 | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid 1,1-dimethylethyl ester;tert-butyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate | C18H20N4O4S |
| 1201190-01-3 | 3-Aminocyclobutanecarboxylic acid hydrochloride | C5H9NO2.HCl |
| 1201194-56-0 | 5-Methyl-2-pyridineacetic acid hydrochloride;(5-Methylpyridin-2-yl)acetic acid hydrochloride | C8H9NO2.HCl |
| 1201326-81-9 | 5-(Methylsulfonyl)-2-pyridinecarboxylic acid methyl ester | C8H9NO4S |
| 1201438-56-3 | Duvelisib;INK 1197; IPI 145; 8-Chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-1(2H)-isoquinolinone | C22H17ClN6O |
| 1201593-65-8 | (alphaS)-alpha-Aminocyclobutanepropanoic acid | C7H13NO2 |
| 1201643-08-4 | BD140;BD140 for Albumin binding assay;2,2-difluoro-6-methyl-4-[(E)-2-(4-propoxyphenyl)ethenyl]-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaene | C21H21BF2N2O |
| 1201643-72-2 | 2-(4-(3-Acetyl-8-bromo-3H-pyrazolo[3,4-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile ;4-(3-Acetyl-8-bromo-3H-pyrazolo[3,4-c]quinolin-1-yl)-alpha,alpha-dimethylbenzeneacetonitrile | C22H17BrN4O |
| 1201645-46-6 | N-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-acetamide | C13H19BN2O3 |
| 1201657-32-0 | alpha,alpha-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetic acid ethyl ester | C15H25BN2O4 |
| 1201784-87-3 | 5-Bromo-4-quinazolinamine | C8H6BrN3 |
| 1201784-90-8 | 6-Bromopyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione | C6H4BrN3O2 |
| 1201785-01-4 | 5,6,7,8-Tetrahydro-2,6-naphthyridin-1(2H)-one hydrochloride (1:1) | C8H10N2O.HCl |
| 1201902-80-8 | 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid | C20H23BCl2N2O9 |
| 1201905-61-4 | (E)-2-(2-Ethoxyvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C6HCl4NO2 |
| 1201913-82-7 | Tofogliflozin hydrate (1:1);(1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol hydrate (1:1) | C22H26O6.H2O |
| 1201924-32-4 | 6-Chloro-3-methylpyridine-2-carboxylic acid | C7H6ClNO2 |
| 1202003-49-3 | N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine | C27H34N2O6 |
| 1202055-32-0 | NMS P715;N-(2,6-Diethylphenyl)-1-methyl-8-[[4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide | C35H39F3N8O3 |
| 1202235-68-4 | 5-hydroxy-8-(1-hydroxy-2-(2-methyl-1-o-tolylpropan-2-ylamino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one | C21H26N2O4 |
| 1202237-88-4 | 5-Bromo-2-thiazolecarboxylic acid ethyl ester | C6H6BrNO2S |
| 1202249-72-6 | 4,6-Dibromo-3-fluoro-2-n-heptylcarbonylthieno[3,4-b]thiophene | C14H15Br2FOS2 |
| 1202357-66-1 | 2-[(6-Chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxylic acid ethyl ester | C11H11ClN4O2S |
| 1202362-88-6 | 3-Methyl-9-phenyl-9H-carbazole | C19H15N |
| 1202402-40-1 | 7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine | C20H21N7O3 |
| 1202450-64-3 | 6-Bromoimidazo[1,2-a]pyridin-8-ol | C7H5BrN2O |
| 1202478-42-9 | (S)-Cyclobutyl(phenyl)methanamine hydrochloride | C11H15N.HCl |
| 1202579-25-6 | (3R,4S)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(2-propen-1-yloxy)phenyl]-2-azetidinone | C27H23F2NO3 |
| 1202645-50-8 | Valganciclovir EP Impurity C;2-amino-9-(methoxymethyl)-1H-purin-6-one | C7H9N5O2 |
| 1202656-18-5 | 1,3-Dichloro-5-propoxybenzene | C9H10Cl2O |